Drugs / NaCl
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00936247 Comparator | Nov 2009 → Sep 2010 | impaired renal function disease | B. Braun Melsungen AG | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | “Albumin 5% as colloid component and NaCl 0.9% as electrolyte component” NCT00936247 ↗ |